| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8471138 | Genes & Diseases | 2018 | 5 Pages |
Abstract
CDV3 is correlated with tumorigenesis and may affect some biological process in cancer. In this study, we explore the role of CDV3 in HCC. According to the TCGA data base, CDV3 is over-expressed in HCC tissues. Up-regulation of CDV3 is correlated with lower over-all survival rate in HCC patients. In HCC samples from our hospital, CDV3 is also enriched in cancer tissues and CDV3 expression associated with HCC pathological T stage. What is more, higher CDV3 expression could forecast poor survival rate in HCC patients. In conclusion, CDV3 is a biomarker of HCC and could be a potential therapeutic target.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Heng Xiao, Baoyong Zhou, Ning Jiang, Yunshi Cai, Xiongwei Liu, Zhengrong Shi, Ming Li, Chengyou Du,